Original Literature | Model OverView |
---|---|
Publication
Title
Molecular mechanisms of macrophage activation and deactivation bylipopolysaccharide: roles of the receptor complex.
Affiliation
Japanese Red Cross, Hokkaido Red Cross Blood Center, Yamanote 2-2, Nishi-ku,Sapporo 063-0002, Japan. fujihara@hokkaido.bc.jrc.or.jp
Abstract
Bacterial lipopolysaccharide (LPS), the major structural component of the outerwall of Gram-negative bacteria, is a potent activator of macrophages. Activatedmacrophages produce a variety of inflammatory cytokines. Excessive production ofcytokines in response to LPS is regarded as the cause of septic shock. On theother hand, macrophages exposed to suboptimal doses of LPS are rendered tolerantto subsequent exposure to LPS and manifest a profoundly altered response to LPS.Increasing evidence suggests that monocytic cells from patients with sepsis andseptic shock survivors have characteristics of LPS tolerance. Thus, anunderstanding of the molecular mechanisms underlying activation and deactivationof macrophages in response to LPS is important for the development oftherapeutics for septic shock and the treatment of septic shock survivors. Overthe past several years, significant progress has been made in identifying andcharacterizing several key molecules and signal pathways involved in theregulation of macrophage functions by LPS. In this paper, we summarize thecurrent findings of the functions of the LPS receptor complex, which is composedof CD14, Toll-like receptor 4 (TLR4), and myeloid differentiation protein-2(MD-2), and the signal pathways of this LPS receptor complex with regard to bothactivation and deactivation of macrophages by LPS. In addition, recenttherapeutic approaches for septic shock targeting the LPS receptor complex aredescribed.
PMID
14609719
|
Entity
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
LPS:LBP
--
e11
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m11
0
infinite
0
--
CD14
--
e12
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m12
0
infinite
0
--
LPS:CD14
--
e13
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m13
0
infinite
0
--
LPS:TLR4:MD2:MYD88_dimer:MAL:IRAK1:IRAK4
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
TLR4
--
e15
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m15
0
infinite
0
--
MD2
--
e16
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m16
0
infinite
0
--
TLR4:MD2
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
LPS:TLR4:MD2
--
e18
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m18
0
infinite
0
--
LPS:TLR4:MD2:MYD88_dimer:MAL:IRAK1{p}:IRAK4
--
e19
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
(MYD88)2
--
e20
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m20
0
infinite
0
--
LPS:TLR4:MD2:MYD88_dimer
--
e21
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m21
0
infinite
0
--
IRAK1
--
e22
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m22
0
infinite
0
--
LPS:TLR4:MD2:MYD88_dimer:MAL
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
csml-variable:Double
m24
0
infinite
0
--
IRAK1{p}
--
e25
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
csml-variable:Double
m26
0
infinite
0
--
TRAF6
--
e27
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
IRAK1{p}:TRAF6
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
MAPK{active}
--
e30
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
AP-1
--
e31
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m31
0
infinite
0
--
AP-1{active}
--
e32
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m32
0
infinite
0
--
csml-variable:Double
m33
0
infinite
0
--
csml-variable:Double
m34
0
infinite
0
--
IkappaBalpha:NF-KappaB
--
e35
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m35
0
infinite
0
--
IkappaBalpha{p}:NF-kappaB
--
e36
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
IkappaB{ub}:NF-kappaB
--
e37
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
protein remnants
--
e38
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m38
0
infinite
0
--
NF-kappaB
--
e39
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
NF-kappaB
--
e40
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m40
0
infinite
0
--
csml-variable:Double
m41
0
infinite
0
--
csml-variable:Double
m42
0
infinite
0
--
MAL
--
e43
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m43
0
infinite
0
--
IRF3
--
e45
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m45
0
infinite
0
--
IRF3{p}
--
e46
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
IRF3{p}
--
e47
cso30:c:Protein
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m47
0
infinite
0
--
csml-variable:Double
m48
0
infinite
0
--
csml-variable:Double
m49
0
infinite
0
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
LBP
--
e6
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
IRAK1{p}{ub}:TRAF6
--
e65
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m65
0
infinite
0
--
e66
--
e66
cso30:c:EntityBiological
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m66
0
infinite
0
--
HSP90:HSP70:CXCR4:GDF5
--
e67
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m67
0
infinite
0
--
HSP90:HSP70:CXCR4:GDF5:LPS
--
e68
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m68
0
infinite
0
--
csml-variable:Double
m69
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
csml-variable:Double
m70
0
infinite
0
--
csml-variable:Double
m71
0
infinite
0
--
RIP2
--
e72
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m72
0
infinite
0
--
csml-variable:Double
m73
0
infinite
0
--
csml-variable:Double
m74
0
infinite
0
--
RIP2:IKKgamma
--
e75
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m75
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m6*m5*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c21 : 1
stoichiometry:c30 : 1
m29*m28*0.1
nodelay
--
0
PMID: 14609719 TRAF6 activates MAPK kinases.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c34 : 1
stoichiometry:c33 : 1
m31*m30*0.1
nodelay
--
0
PMID: 14609719 TRAF6 activates MAPK kinases,which can lead to AP-1 activation through MAPK.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c22 : 1
stoichiometry:c85 : 1
stoichiometry:c36 : 1
m33*m28*m75*0.1
nodelay
--
0
PMID: 14609719 TRAF6 activates the inhibitors of ¦ÊB (I¦ÊB) kinase (IKK) complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c38 : 1
stoichiometry:c40 : 1
stoichiometry:c39 : 1
m35*m34*0.1
nodelay
--
0
PMID: 14609719 The IKK complex is composed of 2 catalytic subunits IKK¦Á and IKK¦Â and one regulatory subunit IKK¦Ã and induces phosphorylation of I¦ÊB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m36*0.1
nodelay
--
0
PMID: 14609719 The phosphorylation of the I¦ÊBs results in their polyubiquitination, which in turn leads to their 26S proteasome-mediated degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
m37*0.1
nodelay
--
0
PMID: 14609719 The phosphorylation of the I¦ÊBs results in their polyubiquitination, which in turn leads to their 26S proteasome-mediated degradation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m39*0.1
nodelay
--
0
PMID: 14609719 NF-¦ÊB translocates into the nucleus.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m40*0.1
nodelay
--
0
PMID: 14609719 NF-¦ÊappaB translocate into the nucleus and activate the transcription of many ¦ÊB-dependent genes, including TNF-¦Á and I¦ÊB¦Á.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m40*0.1
nodelay
--
0
PMID: 14609719 NF-¦ÊappaB translocate into the nucleus and activate the transcription of many ¦ÊB-dependent genes, including TNF-¦Á and I¦ÊB¦Á.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c23 : 1
stoichiometry:c25 : 1
m43*m21*0.1
nodelay
--
0
PMID: 14609719 TIRAP/Mal binds directly to TLR4. PMID: 14609719,12447441 TIRAP-deficient mice have similar LPS-responsive phenotypes to MyD88-deficient mice with regard to the MyD88-independent pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
stoichiometry:c88 : 1
m11*m12*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c57 : 1
stoichiometry:c56 : 1
m45*m18*0.1
nodelay
--
0
PMID: 14609719 Activation of TLR4 by LPS also induces the phosphorylation and nuclear translocation of IRF3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m46*0.1
nodelay
--
0
PMID: 14609719 Activation of TLR4 by LPS also induces the phosphorylation and nuclear translocation of IRF3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
m47*0.1
nodelay
--
0
PMID: 14609719 Activation of TLR4 by LPS induces the phosphorylation and nuclear translocation of IRF3, which causes up-regulation of a set of genes, including IFN-¦Â.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c68 : 1
stoichiometry:c69 : 1
m28*0.1
nodelay
--
0
PMID: 14609719 Phosphorylated IRAK-1 first binds TRAF6, resulting in the activation of NF-¦ÊB. The phosphorylated IRAK-1 is then degraded in an ubiquitination-dependent pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m65*0.1
nodelay
--
0
PMID: 14609719 Phosphorylated IRAK-1 first binds TRAF6, resulting in the activation of NF-¦ÊB. The phosphorylated IRAK-1 is then degraded in an ubiquitination-dependent pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
stoichiometry:c93 : 1
m13*m67*0.1
nodelay
--
0
PMID: 14609719 LBP transfers LPS to membrane CD14, and the intercalated LPS is released in lipid membrane; subsequently,the intercalated LPS binds to a complex of receptors composed of chemokine receptor 4, growth differentiation factor 5, and heat shock proteins 70 and 90 in lipid rafts.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m69*m70*0.1
nodelay
--
0
PMID: 14609719, 12791997 Nod1 specifically detects a diaminopimelate-containing N-acetylglucosamine-N-acetylmuramic acid tripeptide motif of peptidoglycan found in Gram-negative bacteria.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
stoichiometry:c81 : 1
m71*m72*0.1
nodelay
--
0
PMID: 14609719,11894097 Nod1 activates NF-¦ÊB through its association with the receptor-interacting protein 2 (Rip2), a CARD-containing serine/threonine kinase that directly interacts with IKK¦Ã, the regulatory subunit of the IKK complex.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c8 : 1
stoichiometry:c10 : 1
m16*m15*0.1
nodelay
--
0
PMID: 14609719 MD-2, a small protein that lacks a transmembrane domain, is identified to associate with the extracellular domain of TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c13 : 1
stoichiometry:c29 : 1
stoichiometry:c90 : 1
m22*m49*m23*0.1
nodelay
--
0
PMID: 14609719 Dimers of MyD88 bind IRAK-1and IRAK-4 bringing the respective domains in close association,resulting in the phosphorylation of IRAK-1 by IRAK-4, which may induce the kinase activity of IRAK-1 leading to its autophosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c94 : 1
m14*0.1
nodelay
--
0
PMID: 14609719 Dimers of MyD88 bind IRAK-1and IRAK-4 bringing the respective domains in close association,resulting in the phosphorylation of IRAK-1 by IRAK-4, which may induce the kinase activity of IRAK-1 leading to its autophosphorylation.
p34
p34
cso30:i:ME_Autophosphorylation
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c55 : 1
m14*m19*0.1
nodelay
--
0
PMID: 14609719 Dimers of MyD88 bind IRAK-1and IRAK-4 bringing the respective domains in close association,resulting in the phosphorylation of IRAK-1 by IRAK-4, which may induce the kinase activity of IRAK-1 leading to its autophosphorylation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c75 : 1
stoichiometry:c14 : 1
stoichiometry:c92 : 1
m17*m68*0.1
nodelay
--
0
PMID: 14609719 CD14 concentrates LPS and presents it to TLR4-MD-2. TLR4, MD-2 and CD11b/CD18 are recruited to the rafts, thereby triggering multiple signaling cascades (i.e., activation of NF-¦ÊB and MAPK).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c17 : 1
m18*m20*0.1
nodelay
--
0
PMID: 14609719 The TIR domain of MyD88 associates with the TIR domain of TLR and IL-1 receptor.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c52 : 1
stoichiometry:c63 : 1
stoichiometry:c62 : 1
m24*m26*m74*0.1
nodelay
--
0
PMID: 1469719 The IKK complex is composed of 2 catalytic subunits IKKa and IKKb and one regulatory subunit IKKg and induces phosphorylation of IkappaB. PMID: 1469719,11894097 Nod1 activates NF-kB through its association with the receptor-interacting protein 2 (Rip2), a CARD-containing serine/threonine kinase that directly interacts with IKKg, the regulatory subunit of the IKK complex. Studies using Rip2-deficient cells have demonstrated that Rip2 is essential for the activation of NF-kB by Nod1 and Nod2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
stoichiometry:c67 : 1
m74*m73*0.1
nodelay
--
0
PMID: 1469719,11894097 Nod1 activates NF-kB through its association with the receptor-interacting protein 2 (Rip2), a CARD-containing serine/threonine kinase that directly interacts with IKKg, the regulatory subunit of the IKK complex. Studies using Rip2-deficient cells have demonstrated that Rip2 is essential for the activation of NF-kB by Nod1 and Nod2.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c24 : 1
stoichiometry:c19 : 1
stoichiometry:c37 : 1
m19*0.1
nodelay
--
0
PMID: 14609719 IRAKs are subsequently phosphorylated and are dissociated from the receptor complex. IRAKs associate receptor complex transiently.(Fig3)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m25*m27*0.1
nodelay
--
0
PMID: 14609719, 9625770, 8599092 IRAKs are subsequently phosphorylated and are dissociated from the receptor complex and interact with another adaptor molecule, TRAF6.
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--